• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AGN 4.65% 61.5¢

ARGENICA THERAPEUTICS LIMITED

Argenica Therapeutics Limited is an Australia-based clinical drug development company.... Argenica Therapeutics Limited is an Australia-based clinical drug development company. The Company is focused on developing therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to improve patient outcomes. The Company's lead candidate, ARG-007, is a cationic arginine-rich peptide that aims to protect brain cells and reduce cell death following a stroke, and other types of neural injury, in order to minimize the impact of these conditions and improve patient recovery. ARG-007 has been successfully demonstrated to improve outcomes in pre-clinical stroke models, traumatic brain injury (TBI) and hypoxic ischaemic encephalopathy (HIE). More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
AGN
AGN Media thread
2
09/05/24 81 23K
09/05/24 Last post  zac2500 Comments Created with Sketch.  81  Views Created with Sketch.  23K 
AGN 29/04/24 3 1.3K
29/04/24 Last post  TradingHault Comments Created with Sketch.  3  Views Created with Sketch.  1.3K 
AGN 24/04/24 1 524
TRENDING NEWS

What does it take to get a new drug to market in Australia?

NEWS
09 May 2024
24/04/24 Last post  TradingHault Comments Created with Sketch.  1  Views Created with Sketch.  524 
AGN 23/04/24 58 13K
23/04/24 Last post  chelseadude65 Comments Created with Sketch.  58  Views Created with Sketch.  13K 
AGN 22/04/24 6 1.1K
22/04/24 Last post  daveg Comments Created with Sketch.  6  Views Created with Sketch.  1.1K 
AGN 22/04/24 0 180
22/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  180 
AGN
News: AGN Argenica Therapeutics Successfully Completes A$12.0M Placement
12/04/24 0 212
12/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  212 
AGN 12/04/24 0 200
12/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  200 

See All Discussions arrow Created with Sketch.

Timeline

DSMB Confirms Safety of First Patients Dosed
29 Apr 09:02
 
Quarterly Activities/Appendix 4C Cash Flow Report
24 Apr 08:47
 
Cleansing Notice
22 Apr 09:18
 
Application for quotation of securities - AGN
22 Apr 09:16
 
Proposed issue of securities - AGN
12 Apr 09:14
 
Proposed issue of securities - AGN
12 Apr 09:14
 
View More arrow Created with Sketch.
(20min delay)
Last
61.5¢
Change
-0.030(4.65%)
Mkt cap ! $75.53M
Open High Low Value Volume
64.5¢ 64.5¢ 60.0¢ $73.94K 120.9K

Buyers (Bids)

No. Vol. Price($)
2 27960 61.0¢
 

Sellers (Offers)

Price($) Vol. No.
61.5¢ 18424 1
View Market Depth
Last trade - 16.10pm 09/05/2024 (20 minute delay) ?
Last
61.5¢
  Change
-0.030 ( 3.91 %)
Open High Low Volume
62.5¢ 62.5¢ 60.0¢ 57573
Last updated 15.10pm 09/05/2024 ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.